From: High-risk surgical stage 1 endometrial cancer: analysis of treatment outcome
Age | Median (Y) | Range |
---|---|---|
65 | 32–83 | |
Pathological stage | Number | % |
Stage – IB | 28 | 26.4 |
Stage – IC | 78 | 73.6 |
Histology grade | Number | % |
II | 51 | 48.1 |
III | 55 | 51.9 |
Histology subtype | Number | % |
Adenocarcinoma | 97 | 91.5 |
No adenocarcinoma | 9 | 8.5 |
Grade and Pathological stage | Number | % |
IB G3 | 28 | 26.4 |
IC G2 | 51 | 48.1 |
IC G3 | 27 | 25.5 |
Radiotherapy type | Number | % |
RT + VB | 92 | 86.8 |
VB | 14 | 13.2 |
Radiotherapy dose Gy | Median | Range |
RT | 45 | 40 – 50.4 |
VB | 24 | 20 – 30 |
Lymphadenectomy | Number | % |
Present | 61 | 57.5 |
Absent | 45 | 42.5 |
Lymphovascular invasion | Number | % |
Present | 73 | 68.9 |
Absent | 33 | 31.1 |